Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg C Hutterer

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
Cancers|December 23, 2023
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder CancerLukas Scheipner, Hanna Zurl, Julia V Altziebler, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
BJU International|February 9, 2008
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinomaGeorg C Hutterer, Pierre I Karakiewicz, Craig Zippe, et al.
International Journal of Cancer|August 11, 2007
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogramGeorg C Hutterer, Jean-Jacques Patard, Paul Perrotte, et al.
Frontiers in Surgery|October 24, 2022
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patientsJohannes Mischinger, Helmut Schöllnast, Hanna Zurl, et al.
BJU International|September 8, 2007
Unclassified renal cell carcinoma: an analysis of 85 casesPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
European Urology|February 17, 2015
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?Sabine D Brookman-May, Matthias May, Ingmar Wolff, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
Cancers|December 23, 2023
Charlson-Deyo Comorbidity Index as a Novel Predictor for Recurrence in Non-Muscle-Invasive Bladder CancerLukas Scheipner, Hanna Zurl, Julia V Altziebler, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
BJU International|February 9, 2008
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinomaGeorg C Hutterer, Pierre I Karakiewicz, Craig Zippe, et al.
International Journal of Cancer|August 11, 2007
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogramGeorg C Hutterer, Jean-Jacques Patard, Paul Perrotte, et al.
Frontiers in Surgery|October 24, 2022
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patientsJohannes Mischinger, Helmut Schöllnast, Hanna Zurl, et al.
BJU International|September 8, 2007
Unclassified renal cell carcinoma: an analysis of 85 casesPierre I Karakiewicz, Georg C Hutterer, Quoc-Dien Trinh, et al.
European Urology|February 17, 2015
Evaluation of the prognostic significance of perirenal fat invasion and tumor size in patients with pT1-pT3a localized renal cell carcinoma in a comprehensive multicenter study of the CORONA project. Can we improve prognostic discrimination for patients with stage pT3a tumors?Sabine D Brookman-May, Matthias May, Ingmar Wolff, et al.
Pageof 8